Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors. The aim of this study was to investigate the validity of the risk of malignancy index (RMI) in premenopausal and postmenopausal patients with adnexal masses.The study involved all women treated for adnexal tumors throughout an 18-month period in the Clinic for Gynecology and Obstetrics, Clinical Center of Serbia (Belgrade, Serbia). On admission, detailed anamnestic and laboratory data were obtained and an expert ultrasound scan was performed. The RMI was calculated for all patients and the obtained data were related to histopathological findings of the tumors. For statistical analysis, we used descriptive and analytical statistics methods and an SPSS computer program.From a total number of 540 women, 85 women had malignant tumors 20 women, borderline tumorsThe RMI was a reliable factor for differentiating benign from malignant adnexal masses in premenopausal and postmenopausal patients.